← FDA Drug Approvals (Drugs@FDA)

REDEMPLO

NDA · New Drug Application · Sponsor: ARROWHEAD · Approved 2025-11-18

Drug application

FDA Application #

NDA219947

Application type

New Drug Application

Brand name

REDEMPLO

Generic name

PLOZASIRAN

Active ingredients

PLOZASIRAN SODIUM

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ARROWHEAD

Manufacturer

Arrowhead Pharmaceuticals, Inc.

First approval

2025-11-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown